Skip to main content
. Author manuscript; available in PMC: 2017 Jan 24.
Published in final edited form as: Biomaterials. 2014 May 13;35(24):6454–6461. doi: 10.1016/j.biomaterials.2014.04.014

Figure 5.

Figure 5

(a) Near-infrared fluorescence scans of Cy5.5 signal in spleen sections harvested from mice 2 h after IV injection of the indicated Cy5.5-labeled nAv treatments. (b) Quantification of mean gray values of spleens for each group (n = 3). *** indicates p < 0.001 comparing LNP + nAv-DNA treatment to all other control treatments.